Euronext Paris · Healthcare
Invest in Ipsen stock from India
Indian and foreign residents can buy Ipsen (IPN) shares directly through Paasa.
By Paasa · Updated
Ipsen at a glance
- Price
- €143.30-€5.80 (3.89%)
- Market cap
- €11.84B
- Day range
- €141.10 – €149.50
- P/E
- 23.11
- Dividend yield
- 1.12%
- Volume
- 119.50K
- 1 month
- -12.14%
- 6 months
- -9.13%
- YTD
- +20.42%
- 1 year
- +26.37%
- 5 years
- +76.91%
Ipsen statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €3.7B | €3.6B | €3.3B | €3.2B | €2.7B |
| Gross profit | €2.6B | €3.0B | €2.7B | €2.6B | €2.3B |
| Operating income | €746.3M | €496.7M | €816.0M | €943.7M | €886.2M |
| Net income | €444.5M | €345.9M | €644.4M | €648.6M | €646.6M |
| Earnings per share | €5.37 | €4.18 | €7.79 | €7.20 | €7.64 |
| EBITDA | €1.1B | €1.2B | €1.1B | €1.1B | €1.1B |
| Total assets | €6.9B | €6.4B | €6.3B | €5.6B | €5.0B |
| Total debt | €867.1M | €426.8M | €462.9M | €771.6M | €786.6M |
| Cash and short-term investments | €1.5B | €679.2M | €528.4M | €1.2B | €814.7M |
| Shareholders' equity | €4.3B | €4.2B | €3.8B | €3.3B | €2.7B |
| Operating cash flow | €1.1B | €915.5M | €865.9M | €953.2M | €871.8M |
| Free cash flow | €1.0B | €133.0M | €749.7M | €700.3M | €453.9M |
| Capital expenditure | −€105.3M | −€782.5M | −€116.2M | −€252.9M | −€417.9M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in EUR; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Eurofins Scientific | ERF.PA | €77.36 | €13.37B |
| bioMérieux | BIM.PA | €77.70 | €9.17B |
| Abivax | ABVX.PA | €81.90 | €7.14B |
| Virbac | VIRP.PA | €303.50 | €2.54B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Ipsen from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search IPN and buy
Find Ipsen by name or by its ticker, IPN, and place your order.
Why invest in Ipsen from India
What Ipsen does
Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the treatment of neuroendocrine tumors and acromegaly; Cabometyx, a tyrosine kinase inhibitor to treat second line pancreatic and extra-pancreatic neuroendocrine tumors; Onivyde, an irinotecan liposome injection for the treatment of pancreatic cancer; Decapeptyl for the treatment of advanced metastatic prostate cancer; Tazverik, a chemotherapy-free EZH2a inhibitor that is in phase III clinical trial fo… Ipsen operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Ipsen stock from India?
Yes. Indian residents and NRIs can buy Ipsen (IPN) shares directly through Paasa. Ipsen is listed on Euronext Paris, in the Drug Manufacturers - Specialty & Generic industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Ipsen shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.